Version 5.4
Homo sapiens Protein: TP53I13
Summary
InnateDB Protein IDBP-38347.5
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol TP53I13
Protein Name tumor protein p53 inducible protein 13
Synonyms
Species Homo sapiens
Ensembl Protein ENSP00000301057
InnateDB Gene IDBG-38345 (TP53I13)
Protein Structure
UniProt Annotation
Function May act as a tumor suppressor. Inhibits tumor cell growth, when overexpressed. {ECO:0000269PubMed:14767535}.
Subcellular Localization Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}; Extracellular side {ECO:0000305}. Cytoplasm {ECO:0000269PubMed:14767535}. Note=Associates with unknown subcellular structures in the cytoplasm.
Disease Associations
Tissue Specificity Expressed in heart, placenta, skeletal muscle, testis, brain and lung.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
Gene Ontology

Molecular Function
Accession GO Term
Biological Process
Cellular Component
GO:0005737 cytoplasm
GO:0005886 plasma membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro
PFAM
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8NBR0
PhosphoSite PhosphoSite-Q8NBR0
TrEMBL K7ERH9
UniProt Splice Variant
Entrez Gene 90313
UniGene Hs.690843
RefSeq NP_612358
HUGO HGNC:25102
OMIM
CCDS CCDS42289
HPRD 14267
IMGT
EMBL AB110209 AB110214 AC104564 AK075341 BC001593 CH471159
GenPept AAH01593 BAC11555 BAD08203 BAD08208 EAW51192 EAW51193 EAW51194

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca